INOTERSEN
UNII 0IEO0F56LV

Substance Identification & Data

This profile provides standardized clinical and technical data for Inotersen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0IEO0F56LV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1492984-65-2 and the RxNorm Concept ID (RxCUI) 2099289. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0IEO0F56LV

CAS Registry Number

1492984-65-2

RxNorm Concept ID

2099289

Detailed Substance Profile

Preferred Name

INOTERSEN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

0IEO0F56LV

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C121667

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

121492004

Unique identification number in the NCBI database of chemical substances.

INN ID

10294

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-06

Identifier assigned by the United States Adopted Names Council.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Inotersen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.